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Abstract
In model organisms, over 2,000 genes have been shown to modulate aging, the collection of which we call the ‘gerontome’.
Although some individual aging-related genes have been the subject of intense scrutiny, their analysis as a whole has been
limited. In particular, the genetic interaction of aging and age-related pathologies remain a subject of debate. In this work, we
perform a systematic analysis of the gerontome across species, including human aging-related genes. First, by classifying
aging-related genes as pro- or anti-longevity, we define distinct pathways and genes that modulate aging in different ways.
Our subsequent comparison of aging-related genes with age-related disease genes reveals species-specific effects with strong
overlaps between aging and age-related diseases in mice, yet surprisingly few overlaps in lower model organisms. We dis-
cover that genetic links between aging and age-related diseases are due to a small fraction of aging-related genes which also
tend to have a high network connectivity. Other insights from our systematic analysis include assessing how using datasets
with genes more or less studied than average may result in biases, showing that age-related disease genes have faster molec-
ular evolution rates and predicting new aging-related drugs based on drug-gene interaction data. Overall, this is the largest
systems-level analysis of the genetics of aging to date and the first to discriminate anti- and pro-longevity genes, revealing
new insights on aging-related genes as a whole and their interactions with age-related diseases.
Introduction
Aging is a major social and medical challenge of the 21st cen-
tury. The most accepted mechanisms of aging include inflam-
mation (1), apoptosis, oxidative stress, accumulation of DNA
damage, cell cycle deregulation and mitochondrial dysfunction
(2–4). In addition, one of the major breakthroughs in the field of
aging research is the discovery that, in model organisms, aging
is under genetic regulation (5). In the past 20 years, aging has
been shown to be under genetic control in various short-lived
model organisms, and in particular in yeast, worms, flies and
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mice. According to the GenAge database (6), over 2,000 genes
can modulate aging and/or longevity in model organisms. We
call the collection of these aging-related genes the ‘gerontome’
(7). Many of these genes work in common pathways (4), which
include the insulin-like growth factor (IGF-1) signalling path-
way, the target of rapamycin (TOR) pathway and the AMP ki-
nase pathway (5).
Although some individual aging-related genes have been the
subject of intense scrutiny, their analysis as a whole has been
limited (8–11). Yet genes and proteins do not act individually.
Therefore, biological networks provide a more realistic descrip-
tion of biological systems than single-molecule studies and give
way to the integration of several types of data (12). Indeed, net-
work analyses have already revealed insights on aging and its
manipulation (13–15).
Aging is associated with various diseases. The main catego-
ries of aging-related pathologies are: cancer, cardiovascular dis-
eases, neurodegenerative diseases, nutritional and metabolic
diseases (16–18). The relationship between aging and age-
related diseases has long been a contentious topic. A previous
study has shown that the analysis of networks can uncover
links between aging-related genes and age-related diseases (19),
but many questions remain unanswered, like which aging-
related genes and pathways are important in these interac-
tions? Moreover, we have further classified aging-related genes
as anti- or pro-longevity, depending on how they are genetically
manipulated and whether they increase or decrease lifespan in
model organisms (6). Whether and how anti- and pro-longevity
genes interact with aging disease-related genes is unknown.
In this work, we performed a systematic analysis of the ger-
ontome, the largest such analysis to date and the first to dis-
criminate anti- and pro-longevity genes. Our analysis of
pathways common to aging-related genes allows us to system-
atically classify pathways as anti- or pro-longevity, even though
these mostly recapitulate previous findings. By contrast, our
comparison of aging-related genes with age-related disease
genes reveals several unexpected results: we found an associa-
tion between aging-related genes and age-related diseases, yet
this association is surprisingly organism-specific and driven by
a small cluster of genes. Besides, one major issue in network
analysis is whether some genes being better studied than others
(what we call publication bias) impacts the underlying datasets
and subsequent results. We correct for publication bias and
show that a small but detectable fraction of results from
protein-protein interaction network analysis is indeed influ-
enced by whether genes are more studied than others. Lastly,
we identify and rank drugs being targeted by aging-related
genes which are promising for additional studies.
Results
Our systematic analysis of the gerontome employed the
GenAge database developed by our lab (6). This includes 298 hu-
man candidate aging-related genes and genes associated with
aging and/or longevity in model organisms of which over 1,000
can be converted to human homologs (see Materials and
Methods). Model organism aging-related genes were further
classified as pro- or anti-longevity depending on their effects:
pro-longevity genes are defined as genes whose decreased ex-
pression reduces lifespan and/or whose overexpression extends
lifespan; accordingly, anti-longevity genes are those whose de-
creased expression extends lifespan and/or whose overexpres-
sion decreases it (6) (Materials and Methods). This work is the
first to consider such classification in a systematic way.
Processes and pathways overrepresented in pro- and
anti-longevity genes
First, we performed a functional enrichment analysis of pro-
and anti-longevity genes in each of the major model organisms.
For pro-longevity genes, the most significant enriched pathways
were p53-signalling pathway and cell cycle in mice; hypoxia re-
sponse via HIF activation in Drosophila melanogaster; regulation
of autophagy and oxidative phosphorylation in C. elegans
(Supplementary Dataset 1). On the other hand, for anti-
longevity genes, insulin signalling, growth hormone signalling
and IGF-1 receptor pathways were overrepresented in mice; the
PI3 kinase pathway, oxidative phosphorylation and IGF path-
way in Drosophila; oxidative phosphorylation, mTOR signalling
pathway in C. elegans; ribosome in Saccharomyces cerevisiae.
Some pathways like mTOR signalling, autophagy, insulin sig-
nalling and ribosome were enriched in more than one model or-
ganism (Supplementary Dataset 1).
In addition to the more traditional functional enrichment,
we also used a recently proposed feature selection method,
from the area of data mining (or machine learning) to select rel-
evant biological process Gene Ontology (GO) terms for predict-
ing the pro-longevity or anti-longevity effect of a gene on a
model organism (8). Among the top ranking GO terms identified
by that feature selection method, terms associated with pro-
longevity included apoptotic signalling pathway and cell cycle
checkpoint in mice, lipid metabolic process in Drosophila,
autophagy in C. elegans and telomere organization in S. cerevi-
siae. By contrast, top ranking GO terms associated with anti-
longevity included positive regulation of multicellular organism
growth in mice, sensory perception in Drosophila and translation
in C. elegans (Supplementary Material, Dataset 2).
Although the two aforementioned methods work in very dif-
ferent ways, there is some overlap between their results. In par-
ticular, in the results for mice, both methods found terms
related to insulin signalling or growth to be significantly associ-
ated with anti-longevity; and terms related to the cell cycle
were found to be significantly associated with pro-longevity. In
addition, some terms related to autophagy were found to be sig-
nificantly associated with pro-longevity in C. elegans by both
methods.
These results mostly recapitulate current knowledge of
pathways associated with longevity manipulation in model or-
ganisms. Nonetheless, our results highlight pathways with pro-
and anti-longevity effects and allow us to classify such path-
ways in a more consistent, systematic way.
Pro- and anti-longevity networks are interwined
Next, we tested if aging-related genes interact with each other
and if we can observe the differences between the ways that
pro- and anti-longevity genes form protein interaction net-
works. To perform this analysis, we employed protein-protein
interaction data from BioGRID (see Materials and Methods) and
focused our attention on worm genes, as the dataset of aging-
related genes in worms is by far the largest among the animal
models in GenAge (Table 1).
Out of all the worm genes classified as anti- or pro-longevity
genes (n¼ 719), 283 genes had interactions in the BioGRID inter-
actome (109 pro- and 174 anti-longevity genes). The average
connectivity degree of pro-longevity genes was slightly higher
than that of anti-longevity genes (8.42 compared to 5.43), and
on average, both sets of aging-associated genes included more
connected genes than similarly-sized random sets from the
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interactome (the connectivity degree for the entire interactome
is 3.8). The clustering coefficient of pro-longevity genes was also
higher than that of anti-longevity genes (0.108 compared to
0.063), showing that on average pro-longevity genes tend to
cluster better than anti-longevity genes.
In addition, we found that pro- and anti-longevity genes are
much intertwined, with almost as many protein-protein inter-
actions between genes from opposite categories (80 interac-
tions) as between genes from the same category (43 interactions
between pro-longevity genes and 56 interactions between anti-
longevity genes) (Fig. 1). While pro- and anti-longevity genes
can form two network cores by themselves (28 genes are inter-
connected for each set), they also form a much larger network
when taken together (90 genes), suggesting that the way in
which pro- and anti-longevity genes determine lifespan is in
many cases dependent on one another.
Various previous studies have shown aging-related genes to
form strong networks (9,10,14), as is normal in biology, but our
results expand these observations to pro- and anti-longevity
subnetworks and support substantial interactions between pro-
and anti-longevity genes.
Comparison with longevity-associated human genes
In addition to genetic manipulations in model organisms, a
number of genes have been associated with longevity in human
populations (20). We therefore also performed a functional en-
richment analysis of these genes using data from the
LongevityMap, which consists of 755 human genes, 328 of
which associated with longevity in at least one genetic associa-
tion study (20). For a first functional enrichment analysis using
DAVID (see Materials and Methods), with the background set as
default, 49 clusters showed an enrichment score greater than
2.5 (Supplementary Dataset 3). With the background set as
LongevityMap genes, 62 clusters with an enrichment score> 2.5
were obtained (Supplementary Material, Dataset 3). A similar
functional annotation clustering pattern as seen in the first run
was observed (Supplementary Material, Fig. S1), and major en-
riched clusters consisted of: regulation of apoptosis, regulation
of phosphorylation, response to environment, regulation of lo-
comotion and response to hormone stimulus.
Results from human longevity-associated genes only mod-
estly overlap with the above results for model organisms, al-
though some pathways thought to be related to aging (e.g.,
apoptosis, response to oxidative stress and mTOR signalling)
were found. Enriched clusters also included terms related to
age-related diseases like cancer and diabetes mellitus
(Supplementary Dataset 3). This may reflect how researchers
choose candidate genes for longevity association studies, how-
ever. Perhaps researchers tend to select candidate genes for
their studies that are suspected of playing important roles in
human longevity, or in severe pathological processes that can
significantly impair longevity.
Overlap between aging-related genes and age-related
diseases
Next we aimed to study the genetic overlap between aging and
age-related diseases (ARDs). For this analysis, we used human
genes associated with ARDs from public databases (see
Materials and Methods), human candidate aging-related genes
and human homologs of genes associated with aging in model
organisms from GenAge (6). Common or shared genes between
ARDs and aging gene sets are referred to as common aging and
disease (CAD) genes. In addition to an analysis focused on indi-
vidual age-related diseases, a set named ‘all diseases’ and an-
other named ‘all classes’ were created, composed of all genes
considered in the analyses per individual age-related disease
and per age-related disease class, respectively (Materials and
Methods).
As expected, the human aging-related gene set has the most
associations with ARD genes. In addition, the immune system
and respiratory tract disease classes only show a relation with
aging in human aging-related genes (Fig. 2A). Among the hu-
man homologs of genes associated with aging in model organ-
isms, the musculoskeletal disease class only exhibits a
significant overlap with aging-related genes in the mouse. A de-
crease in the overlap between aging and age-related diseases as
evolutionary distance increases is also clear from our results
(Fig. 2A) with the mouse showing an overlap with more ARDs
when compared with the other model organisms, even though
fewer aging-related genes are known in mice than in flies or
worms. This is also clear from looking at individual ARDs (Fig. 3)
since in mice there is a significant overlap with 9 and 17 ARDs
for anti- and pro-longevity sets, respectively, while the remain-
ing model organisms present the following values: Drosophila - 8
and 3; C. elegans - 5 and 0; and finally S. Berevisiae - 1 and 3.
We also compared overlaps between anti- and pro-longevity
genes. Pro-longevity genes present a higher number of overlap-
ping age-related diseases than anti-longevity genes for all
orthologs (i.e., combining human orthologs of all genes from
model organisms), mouse and S. cerevisiae. The opposite is veri-
fied for Drosophila and C. elegans sets (Fig. 2A).
Supplementary Materials, Tables S6 and S7 include the
P-values and the number of CAD-genes for, respectively,
Table 1. Number of genes plus average and median number of
publications per gene in each dataset
Dataseta Num. of
genes
Average
num. pubs.
Median
num. pubs.
Human genome (NCBI) 20183b 8.7 6
Human interactome (BioGRID) 15000c 10.4 8
Human aging-related genes 298 30.3 23
All aging-related orthologs 894 14.5 10
anti-longevity 448 13.2 9
pro-longevity 421 15.9 11
M. musculus 84 26.8 19
anti-longevity 23 22.7 13
pro-longevity 59 28.6 21
D. melanogaster 135 19.9 13
anti-longevity 48 20.1 12
pro-longevity 87 19.6 13
C. elegans 693 13.1 9
anti-longevity 381 13.0 9
pro-longevity 290 13.1 9
S. cerevisiae 62 17.9 14
anti-longevity 41 14.7 10
pro-longevity 13 23.2 15
Notes:.
aAll datasets refer to human genes, including human orthologs of genes from
various model organisms.
bGenome has 20183 annotated genes in NCBI but only 19071 are in the Swiss-
Prot database.
cInteractome has 15000 annotated genes in NCBI but only 14498 are in the
Swiss-Prot database.
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age-related disease classes and individual diseases. Neoplasms
(1.35E-56), nutritional and metabolic (9.70E-34), cardiovascular
(2.00E-23) and nervous system (1.78E-18) classes have the stron-
gest associations with human aging. There is an additional class
not considered in the individual ARD analysis, the eye diseases,
which presents a positive association with aging only for hu-
man aging-related genes and mouse pro-longevity genes
(Supplementary Materials, Table S6).
Publication bias effects and correction
The inclusion of more and less studied genes may reduce the
accuracy of the results. This is an issue when using large data-
sets that may contain systematic biases. Indeed, we observed a
moderate correlation between the number of publications asso-
ciated with a gene and its number of annotated protein-protein
interactions (Spearman correlation coefficient¼ 0.67). While
this is not unexpected, it could result in biases in systems biol-
ogy analysis. To minimize this issue, a publication bias correc-
tion (PBC) based on the number of publications per gene was
tested.
The first step of the PBC was setting a threshold for differen-
tiation between more and less studied genes. Table 1 shows the
average and the median number of publications computed for
the following gene sets: human genome, human interactome,
human aging-related genes and human homologs of aging-
related genes from model organisms. The sets of aging-related
genes have a higher average (range 13.0 to 30.3) and median
(range 9 to 23) values when compared with the whole genome
(average of 8.7 and median of 6) and the interactome (average of
10.4 and median of 8). This is expected but it shows that aging-
related genes are more studied than average.
Thresholds between 8 and 20 publications were assessed in
order to define the value with which the subsequent analyses
were performed (see Supplementary Material, Fig. S2). Overall,
we used 10 publications as a threshold.
Overlap between aging-related genes and age-related diseases with
publication bias correction
The overlap analysis between aging-related genes and ARD
genes was repeated after applying a filter for PBC (i.e., only con-
taining genes with at least 10 publications). After PBC, the hu-
man aging-related gene set presents a significant overlap
with ARD from all classes except for the immune system class
(Fig. 2B). For the human homologs of aging-related genes from
model organisms, only the mouse and the Drosophila present
significant overlaps with ARDs and the latter only presents sig-
nificant results for the anti-longevity gene set. In the mouse,
pro-longevity genes have a higher number of ARDs overlapping
compared to anti-longevity genes. In the all orthologs gene set,
both anti- and pro-longevity genes show an association with
the neoplasms class. These results are supported by P-values in
Supplementary Materials, Tables S8 and S9, also suggesting a
general stronger overlap with aging of genes associated with
neoplasms and nutritional and metabolic diseases.
Comparing the two analyses without and with PBC, respec-
tively, Figure 2A and B, we observe a decrease in the number of
significant overlapping ARDs with all aging-related gene sets
due to the exclusion of less studied genes. The human aging
gene set is the least affected by the exclusion of less studied
genes since after PBC it presents only a loss of 16% of its genes
(298 to 253 genes). Small reductions are verified in small gene
sets, such as the baker’s yeast and the mouse. The opposite is
verified in bigger gene sets, such as worms, which lose 47% and
50% of genes in anti- and pro-longevity sets, respectively.
Finally, these same patterns are observed comparing
Supplementary Materials, Tables S6–S9, which show statistical
tests for the various overlaps.
Figure 1. Protein–protein interactions between worm aging-related genes. Pro-longevity genes are depicted in red and anti-longevity genes in green. For each of the
two gene sets, the smaller inside ellipse indicates genes that form a continuously connected network. Left right straight and curved arrows are used to summarize un-
directed interactions between genes from different and the same gene set, respectively.
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Figure 2. The y-axis quantifies the number of age-related diseases which significantly overlap with aging-related genes; the x-axis describes the aging-related gene
sets studied according to the source organism (i.e., human plus human homologs of aging-related genes from each model organism). The columns have seven different
colours to represent each age-related disease classe analysed: Neoplasms (light blue), Nutritional and Metabolic diseases (orange), Nervous System diseases (light
grey), Cardiovascular diseases (yellow), Musculoskeletal diseases (blue), Respiratory Tract diseases (green) and Immune System diseases (dark blue). The first column
represents the number of age-related diseases with a significant overlap with candidate human aging-associated genes. Model organisms are ordered by evolutionary
proximity to humans. The genome was considered as background. The secondary y-axis displays the number of genes from the respective gene sets. (A) shows the
number of significant overlapping aging-related genes with age-related diseases. (B) shows the number of significant overlapping aging-related genes with age-related
diseases with PBC (i.e., only genes with more than 10 publications were used).
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Overlap between aging-related genes and age-related diseases in the
interactome
The interactome (15000 genes) is a subset of the genome (20183
genes) within which only genes for which protein-protein inter-
action data is available are present (Table 1). We assessed the
overlap between aging and ARDs genes when restricting the
analysis to genes in the human interactome (Supplementary
Material, Fig. S3). The distribution of aging-related gene overlaps
with ARDs is similar in the interactome (Supplementary Material,
Fig. S3) to the distribution in the whole genome (Fig. 2A), both
without and with PBC. The analyses present similarities in the to-
tal number of genes, the overlap significance (P-values), the num-
ber of CAD-genes, and the relations between age-related diseases
and aging shown by the anti- and pro-longevity sets.
When comparing the whole genome and the interactome
analyses without PBC (Supplementary Materials, Tables S6, S7,
S10 and S11) and the whole genome and the interactome analy-
ses with PBC (Supplementary Materials, Tables S8, S9, S12 and
S13), there is a slight drop in the significance of overlaps with
PBC, suggesting that some (but not all) results are indeed due to
publication bias. Looking at the effect of PBC on the number of
CAD-genes, there is again a slight decrease with PBC in the ma-
jority of ARD classes and individual diseases. We conclude that
publication bias has a modest but noticeable effect on our results.
Since genes function in combination with other genes, study-
ing genes and proteins as part of interaction networks is essen-
tial (21). To study the effect of genes which interact with aging-
related genes in the links between aging and ARDs, we per-
formed an analysis in which aging gene sets were composed of
gene sets from the genome with PBC plus the genes directly con-
nected to them (first order partners). This analysis revealed that
aging-related gene sets including the first order partners are 18
to 51 times larger than the original aging-related gene sets with
PBC (Fig. 4A). This increase in the number of genes is not propor-
tional to the initial gene set size, and human aging-related genes
are the ones that interact more with other genes.
Regarding ARDs classes overlapping with aging-related
genes, neoplasms and nervous system classes do so in all gene
sets analysed. Cardiovascular, as well nutritional and metabolic
classes are also present. Musculoskeletal diseases overlap with
human aging-related genes and then they only overlap with
anti-longevity genes of mice and Drosophila. Finally, respiratory
tract diseases present a significant overlap with aging for the
anti-longevity gene set in C. elegans.
Overall, there is a clear increase in the number of overlap-
ping ARD genes with aging-related genes by including first order
interaction partners, as well as in the number of CAD-genes,
which is supported by a statistical significance analysis
(Supplementary Materials, Tables S14 and S15). Given the large
increase in the number of genes by including first order part-
ners, these results are not surprising but they underscore the
large interconnection of biological networks, including between
aging and age-related diseases.
Co-expression network analysis
Co-expression networks offer a complementary perspective on
biological interactions from protein-protein interaction net-
works. To study co-expression, data were downloaded from the
GeneFriends database (22) and genes co-expressed with aging-
related genes (human candidate genes plus human homologs of
genes associated with aging in model organisms, all following
PBC) were considered (see Materials and Methods). The inclu-
sion of genes co-expressed with aging-related genes again
changes the number of genes per set; and there is an increase
which is proportional to the size of the initial set, i.e., larger sets
have a greater increase in their sizes (Fig. 4B).
At the level of age-related disease classes, neoplasms is the
main class with a significant overlap between aging-related genes
and ARDs genes, followed by the cardiovascular and nervous sys-
tem classes. As before, the human aging-related gene set shows
the highest association with ARDs. Immune system disease genes
seem associated with aging-related genes when considering the
anti-longevity genes of all orthologs together. Interestingly, there
is a difference in overlapping classes between anti- and pro-
longevity gene sets and, except in the mouse, anti-longevity genes
Figure 3. Overlapping aging-related genes for various organisms with age-related disease genes sets. Green means significant overlap between aging-related and age-
related disease genes and red means there is no significant overlap. Model organisms are in descending order of their proximity to humans.
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Figure 4. The y-axis quantifies the number of age-related diseases which significantly overlap with aging-related genes; the x-axis describes the aging-related gene
sets studied according to the source organism (i.e., human plus human homologs of aging-related genes from each model organism). The columns have seven different
colours to represent each age-related disease classe analysed: Neoplasms (light blue), Nutritional and Metabolic diseases (orange), Nervous System diseases (light
grey), Cardiovascular diseases (yellow), Musculoskeletal diseases (blue), Respiratory Tract diseases (green) and Immune System diseases (dark blue). The first column
represents the number of age-related diseases with a significant overlap with candidate human aging-associated genes. Model organisms are ordered by evolutionary
proximity to humans. This analysis was performed with PBC. The secondary y-axis displays the number of genes from the respective gene sets. (A) shows the number
of significant overlapping aging-related genes with age-related diseases, including first order interaction partners. The interactome plus aging-related and age-related
disease genes was considered as background. (B) shows the number of significant overlapping aging-related genes with age-related diseases, including co-expressed
genes. The genome was considered as background.
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present a higher relation to ARDs than pro-longevity genes, which
is very clear in flies and worms (Fig. 5).
In the mouse, the results show that pro-longevity genes
slightly overlap with nervous system disease genes, but the asso-
ciation is verified due to just one disease. In Drosophila, anti-
longevity genes are associated with nutritional and metabolic,
cardiovascular and respiratory tract diseases, while the pro-
longevity genes are associated only with nervous system diseases.
Finally, there is no significant overlap with any age-related dis-
eases in the pro-longevity gene set of worms, even though it con-
tains more than two thousand genes. Moreover, there are a few
CAD-genes (up to 15) which show non-significant overlaps with
the assessed ARDs (Supplementary Materials, Tables S16 and S17).
Because including co-expressed genes increases the number of
starting genes, there is an increase in the number of CAD-genes
when including co-expressed genes. Using the human aging-
related gene set as an example, there are 65 CAD-genes in the over-
lap with neoplasms genes but when including the co-expressed
genes the overlap with neoplasms increases to 131 CAD-genes.
However, the percentage of overlapping genes drops dramatically.
For human aging-related genes, 22% and 0.06% are associated with
ARDs, with and without co-expressed genes, respectively.
Properties of common genes between aging and
age-related diseases
Common genes or CAD-genes from the overlap analyses can
highlight clues about pathways which link aging to disease pro-
cesses. CAD-genes were obtained from the overlap between the
human aging set and ARDs genes from analyses per individual
age-related diseases or per diseases class, both with PBC.
A small subset of aging-related genes are also associated with age-
related diseases
The number of times that each CAD-gene overlaps with ARDs
was defined as its frequency, and allows us to determine if
some genes are involved in several disease processes. Figure 6A
shows the frequency of CAD-genes across all the age-related
disease classes. A total of 94 genes were obtained from the over-
lap between the human aging-related genes and all the ARDs
genes per class. A majority of these genes (approx. 83% genes)
overlap with up to three classes (Fig. 6A). Regarding genes which
overlap with a great number of classes, PON1 and APOE are at
the top (Fig. 6B), as well as some other genes involved in age-
related changes, for example, VEGFA, IL6 and AR. One gene pre-
sent in all ARDs analysed is TNF (tumour necrosis factor).
It is also interesting to explore aging-related genes which
are not associated with any ARDs. The 94 CAD genes represent
37% of the human aging-related genes with PBC (253
genes), which means that most (63%) aging-related genes are
not associated with any ARD class. From the perspective of
ARDs genes (639 genes), about 15% have been related to human
aging.
An analysis of the CAD-genes distribution was also per-
formed by individual ARDs. A total of 90 genes were found to
overlap between human aging-related genes and ARD genes.
Figure 7A shows that the number of genes involved in several
ARDs is small, and about 59% (53 genes) of the 90 genes are as-
sociated with up to three ARDs. The pattern of distribution is
similar to the analysis by ARD class and TNF, PON1, APOE and
VEGFA are the top of CAD-genes among ARDs for both analyses
(per age-related disease class and per individual disease) (Fig.
7B). In this analysis, the percentage of aging-related genes not
associated with any age-related disease is about 64%. Similar to
above, from the perspective of ARD genes (596 genes), only 15%
have been related to human aging.
Pathways and processes linking aging and age-related diseases
A functional enrichment analysis was performed on CAD-
genes. The background used was the set of human aging-
related genes plus ARDs sets. Functional enrichment for CAD-
genes from all analysed ARD classes shows that these genes are
Figure 5. Overlapping aging-related genes and their co-expressed partners with age-related diseases for various classes and organisms. Green means there is at least
one age-related disease from that class that significantly overlaps with aging-related genes and red means no association. Model organisms are in descending order of
their proximity to humans. This analysis was performed without PBC.
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associated with: negative regulation of apoptosis, cell cycle,
positive regulation of DNA, positive regulation of protein meta-
bolic process and response to stimuli (Supplementary Material,
Table S1).
Looking at CAD-genes in individual ARDs, only neoplasms,
nutritional and metabolic, musculoskeletal and eye classes
have significant functional clusters. Relative to neoplasms, CAD-
genes are more associated with negative regulation of apoptosis,
DNA repair, regulation of cell cycle and cancer, which is in line
with cancer aetiology and its relationship to aging (17). CAD-
genes from the nutritional and metabolic class are related to re-
sponse to insulin stimulus and positive regulation of lipid pro-
cess, while CAD-genes for musculoskeletal diseases only show
an association with the extracellular region. Finally, eye diseases
Figure 6. (A) CAD-genes distribution as associated with age-related disease classes. (B) shows the genes involved in half or more disease classes. TNF is associated with
all the age-related disease classes analysed. This analysis was performed with PBC.
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CAD-genes seem to be associated with positive regulation of RNA
metabolic process (Supplementary Material, Table S1).
Increased network connectivity in genes common to aging and age-
related diseases
Network approaches consider as a measure of node (gene) rele-
vance the node’s degree, which represents the number of
connections of each node. This measure helps to define hubs,
which in general are deemed essential nodes with many connec-
tions. To understand if CAD-genes are likely to be hubs, a com-
parison between the degree of CAD-genes and ARD genes or
aging-related genes (the non-common genes) was made using
protein-protein interaction data (Supplementary Material,
Table S2).
Figure 7. (A) CAD-gene distribution as associated with individual age-related diseases. (B) shows the CAD-genes involved in ten or more individual diseases, with
PON1, TNF, APOE the top 3 genes associated with the greatest number of age-related diseases. This analysis was performed with PBC.
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Age-related disease class analysis shows significant differ-
ences in node degree between CAD-genes and controls (P-val-
ue< 0.001). The median node degree of CAD-genes (47) is
substantially higher than the median for the control set (11).
Looking at ARD classes, only two classes have a significant
(P< 0.05) difference between the two sets investigated: neo-
plasms and immune system diseases. Neoplasms present a
higher median for CAD-genes (47) compared to the control set
(23.5), while for the immune system class the opposite is veri-
fied (8.5 vs 43) (Supplementary Material, Table S2).
The results from the analysis per individual ARDs show a
significant difference in the number of node connections for
four diseases: atherosclerosis (P¼ 0.002), breast neoplasm
(P¼ 0.020), hypersensitivity (P¼ 0.019) and osteoporosis
(P¼ 0.039). Except for breast neoplasm, the median for CAD-
genes is lower when compared to the ARD genes
(Supplementary Material, Table S2).
Processes associated with aging-related genes not associated with
age-related diseases
A functional enrichment was performed for genes from the hu-
man aging gene set which are not associated with any ARD. The
main processes in the functional enrichment are: response to
DNA damage, negative regulation of apoptosis, ATP-binding,
negative regulation of transcription, DNA repair, aging, telo-
mere maintenance, response to several stimuli, negative regula-
tion of gene expression, cancer and signalling pathways (for
examples, insulin, IL3 and MAPKinase). Of these terms, the ones
with the higher cluster scores are response to DNA damage and
negative regulation of apoptosis. The full list of significantly en-
riched terms is in Supplementary Material, Table S3.
Molecular evolutionary rates of aging- and disease-
related genes
Aging-related and disease-related genes are also known to
differ from the genome-wide average at the level of selection
pressures. The study this, the dN/dS ratio between humans and
mice of the human aging-related genes and the ARD genes sets
was analysed and compared to the remaining genome (see
Materials and Methods). Results show a significant (p< 0.001)
difference between ARD genes and the other genes in the ge-
nome, wherein ARD genes have a higher median dN/dS ratio
(0.137) than the whole genome (0.091). Although there was a dif-
ference between aging (median of 0.079) and non-aging genes
(median of 0.093), this was not statistically significant (p-
value¼ 0.155).
The dN/dS ratio was also assessed in anti- and pro-longevity
genes. A difference in dN/dS ratio between anti- and pro-
longevity genes was only observed in C. elegans (p-value¼ 0.046,
which is not significant after Bonferroni correction), so we find
no evidence of differences in molecular evolution rates between
anti- and pro-longevity genes.
Searching for patterns and features which could define CAD-
genes, their molecular evolutionary (dN/dS) rate was analysed
in comparison with aging-related genes and ARD genes. The
CAD-genes used were from the overlaps of the three ARD clas-
ses with more genes: all classes together, neoplasms and nutri-
tional and metabolic diseases. No statistically significant
differences were found, suggesting that molecular evolution
rates of CAD-genes are not different from other aging and ARD
genes.
Drugs predicted from aging-related gene interactions
with drugs
Given the large number of aging-related genes and pathways
identified, there is great interest in identifying drugs that target
them and may potentially have clinical benefits (23). To obtain
candidate drugs affecting the aging process, we employed pub-
licly available drug-gene interaction data (see Materials and
Methods). In total, 376 drugs whose targets overlapped with
aging-related genes were obtained. Twenty statistically-
significant drugs that have more interactions with aging-related
genes than expected by chance were obtained after Bonferroni
correction (Supplementary Material, Table S4).
The majority of the drugs obtained from this analysis were
histone deacetylase inhibitors used for the treatment of cancer.
This might be due to an overrepresentation of cancer drugs in
public databases. Nonetheless, three known lifespan-extending
drugs were identified: sodium phenylbutyrate, valproic acid and
everolimus (Supplementary Material, Table S4). The fact that
experimentally validated aging-related drugs are detected by
our methodology suggests that this approach may be useful to
identify new candidate drugs with effects on aging.
Discussion
To our knowledge, ours is the largest analysis of the gerontome
to date, and the first to consider pro- and anti-longevity genes
in a systematic fashion. We first characterized functions and
pathways overrepresented in pro- and anti-longevity genes.
Major anti-longevity pathways and processes include insulin
signalling, growth hormone signalling and mTOR signalling.
Key pro-longevity pathways include p53, cell cycle and autoph-
agy. Although such pathways and processes are known to be re-
lated to aging (2,4,5,24), it is interesting that they are classified
as anti-and pro-longevity in our systematic analysis of the ge-
netics of aging. Differentiation between anti-longevity and pro-
longevity genes and processes can provide additional clues
about aging-related processes and can help identify other genes
with a similar effect on aging.
In order to find relations between aging and ARDs, we com-
pared aging-related gene sets with ARD genes. Limitations of
our study include the fact that possibly many genes associated
with longevity and diseases remain to be identified, and the
causal genes in many genetic associations with disease are still
unknown. In spite of these caveats, our results show an associa-
tion between aging and ARDs at the genetic level, although this
is surprisingly species-specific with a stronger overlap in mice
than in invertebrates (flies and worms) and practically no over-
lap in yeast.
The overlap analyses of anti- and pro-longevity genes shows
differences in musculoskeletal, nervous system and cardiovas-
cular diseases. The identified overlaps suggest that the muscu-
loskeletal and nervous systems are related to pro-longevity
genes while anti-longevity genes seem more associated with
cardiovascular diseases. Looking at ARD classes which overlap
with human aging-related genes, a significant overlap is verified
for all classes as expected, except for immune system diseases
in the analysis with PBC. The nutritional and metabolic dis-
eases, the neoplasms, the cardiovascular diseases and the ner-
vous system diseases have the most significant overlap with
human aging-related genes. Eye diseases, respiratory tract dis-
eases (which we considered a negative control) and immune
system diseases had the least overlap, but it is important to
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mention that these are (together with musculoskeletal diseases)
the age-related disease classes with fewer genes (Fig. 8).
Genes historically associated with diseases are more likely
to be studied. A publication bias correction approach, based on
the number of publications associated with each gene, was ap-
plied in order to explore and reduce such biases. The analyses
with and without PBC, when compared, show the effect of the
removal of less studied genes (Fig. 2A vs. B). The overlaps for C.
elegans and S. cerevisiae disappear when the PBC is applied,
which supports the hypothesis that some overlaps are statisti-
cally significant only due to an overrepresentation of better-
studied genes. The comparison of analyses with and without
PBC proves that systematic researcher biases can influence the
results in large-scale systems biology, genomic and genetic
analysis.
From our network analysis including the first order protein-
protein interaction partners, it is possible to conclude that
aging-related genes are widely connected to other genes, which
is supported by the huge increase in gene sets’ sizes (Fig. 4A).
There is an increase in the number of CAD-genes (the common
or shared genes by aging and ARD) when including the first or-
der partners, which suggests widespread interactions between
aging-related genes and genes associated with age-related dis-
eases. The results are also in agreement with recent research
using genome-wide association studies (GWAS) data, which
showed the same conclusion for five age-related categories:
neurodegenerative, cancers, cardiovascular, metabolic and
other diseases (25). A co-expression analysis of the links be-
tween aging and ARDs supports the idea of species-specific ef-
fects, but with more anti-longevity genes in invertebrates being
related to ARDs. It is tempting to speculate that perhaps anti-
longevity genes work together more tightly in transcriptional
networks than pro-longevity genes.
Previous studies of the association between aging and dis-
eases have demonstrated that the association is established by
a small number of genes (25). Indeed, in the present analysis,
CAD-genes represent a minority of the aging-related genes.
CAD-genes are mainly related to apoptosis, metabolic regula-
tion and DNA damage. These processes are similar to those pre-
viously reported to be associated with aging and may hint at
underlying mechanisms important in various age-related dis-
eases. CAD-genes also showed a higher number of connections
with other genes than the remaining genome, which suggests
that those genes tend to be hubs in networks. TNF, PON1, APOE
and VEGFA are present in a great number of ARDs, which is in
line with their involvement in some of the essential pathways
whose disruption compromises metabolism and can lead to pa-
thologies (26,27).
The dN/dS ratio analysis showed a statistically significant
higher dN/dS ratio of ARD genes when compared to the remain-
ing genome, while aging-related genes had a lower dN/dS ratio
that was not statistically significant. Therefore, we can affirm
that ARD genes have a higher predisposition to changes in their
sequence than aging-related genes. These results are in line
with previous findings: an analysis using a previous version of
GenAge found that aging-related genes have a lower dN/dS ratio
(28). One previous study found a higher molecular evolutionary
rate in disease genes (29). Our results further suggest that
aging-related genes tend to be evolutionarily conserved, per-
haps because they are part of essential pathways and conserved
pleiotropic effects on aging (28), while genes associated with
age-related diseases may be under relaxed selection given that
they impact later in life.
Finally, taking advantage of a database of gene-drug interac-
tions, we mapped GenAge’s genes to drugs and obtained a list
of 20 candidate drugs for aging effects. Of these, three are
Figure 8. Number of genes by age-related disease class (Total column) and shared with each other disease classes. The white cells present the number of genes shared
between disease classes and the darker grey cells show the number of genes not shared with any other disease class.
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already experimentally validated and the rest is yet to be ex-
plored. As such, these compounds are promising for future
studies.
Concluding Remarks
The main conclusion from this work is that aging and age-
related diseases are related and share more genes than ex-
pected by chance. Human aging-related genes showed a consid-
erable overlap with ARDs. These overlaps are driven by a small
subset of aging-related genes which are associated with various
age-related diseases and are hubs in networks. Besides, the ex-
tent of overlaps decreases with evolutionary distance, and yeast
aging-related genes show practically no overlap with ARDs.
Novel differences in overlapping age-related disease classes be-
tween anti- and pro-longevity genes were observed: Nervous
system and musculoskeletal diseases seem more associated
with pro-longevity, while cardiovascular diseases have a stron-
ger association with anti-longevity genes. Moreover, network
analyses (protein-protein interactions (PPI) and co-expression)
suggest the existence of intermediate genes which promote the
associations between aging and age-related disease genes.
Overall, our work establishes a new standard in the analysis of
aging-related genes in a systematic way.
Materials and Methods
Aging- and longevity-associated genes
Aging-associated genes were obtained from GenAge Build 17 (6).
These include 298 human candidate aging-related genes.
GenAge also includes aging- or longevity-related genes in model
organisms. For use with human datasets, human orthologs of
model organism genes were used, composed of 1037 genes from
the four main biomedical model organisms: mouse, fruit fly,
roundworm and baker’s yeast. The genes of each model organ-
ism were separated by their longevity classification: anti- or
pro-longevity. Pro-longevity genes are genes whose decreased
expression (due to knockout, mutations or RNA interference) re-
duces lifespan and/or whose overexpression extends lifespan;
conversely, anti-longevity genes are those whose decreased ex-
pression extends lifespan and/or whose overexpression de-
creases it (6). Genes which were not included in one of these
two longevity classes were excluded. A small number (19) of
genes with both anti- and pro-longevity classifications were
also excluded.
To sum up the data, aging-related genes were divided into 11
gene sets: one set of 298 human aging-related genes, two sets
(anti- and pro-longevity) of human orthologs from each model or-
ganism and two sets with all human orthologs of genes in all
model organisms. The mouse sets (i.e. human orthologs of genes
associated with aging in mice), have 23 and 59 genes, the fruit fly
sets have 48 and 87 genes, the roundworm sets have 381 and 290
genes, and lastly the baker’s yeast sets have 41 and 13 genes, re-
spectively anti- and pro-longevity (Supplementary Materials,
Table S18). Finally, sets with all orthologs have 448 and 421 genes,
anti- and pro-longevity sets, respectively. The full lists of human
aging-related genes and human orthologs are available in the sup
plementary material (Supplementary Dataset 4).
Data on human genes associated with longevity in genetic
association studies were obtained from the LongevityMap build
1 (20). In the full set of 755 genes, there were 328 genes with at
least one significant result reported.
Age-related disease genes
Age-related disease (ARDs) genes were assembled on 15-04-
2015 from a diseases list compiled by a National Institute of
Aging study. The list only includes genes with an association
with the disease phenotype and with a MeSH annotation (30).
This list is available online (https://www.irp.nia.nih.gov/
branches/rrb/dna/gene_sets.htm) and it was compiled using in-
formation from the Genetic Association Database (30).
The original list includes many diseases not relevant for the
present analysis since our interest focuses on complex ARDs.
To select relevant ARDs, diseases with fewer than 20 genes as-
sociated and diseases of non-age-related disease classes were
excluded. We chose a threshold of 20 genes because it captures
the major age-related diseases yet not so many diseases that
our findings end up being diluted (Supplementary Material,
Table S19). The original list also includes processes and condi-
tions, for example, insulin resistance and hyperlipidemia,
which are dysfunctions, and for that reason were also excluded.
The following analysed classes were described as age-related in
the literature: cardiovascular diseases, eye diseases, immune
system diseases, musculoskeletal diseases, nervous system dis-
eases, nutritional and metabolic diseases and neoplasms (2,31).
Respiratory tract diseases were considered as negative controls
since the two diseases (after application of the described selec-
tion criteria) in this class are asthma, which is not considered
an age-related disease (32), and chronic obstruction pulmonary
disease, which is primarily environmental.
Selection of individually studied ARDs was made based on
two criteria: first, the number of genes, to have larger sample
sizes and increase statistical power. The second criterion was
how often and common was each disease. An example of selec-
tion is the case of ovarian neoplasm, which presents a smaller
number of genes and is better known than head and neck neo-
plasms. In order to have a representative selection, seven dis-
eases classes were included in the individual age-related
disease analysis; for classes with a large number of diseases, we
selected the top five or six most representative individual dis-
eases of the class. Eye diseases were excluded from the individ-
ual disease analysis, since they include only non-common
diseases with a small number of genes. Diseases that are pri-
marily driven by environmental factors, like chronic obstruction
pulmonary disease, were also not studied.
In total, 893 different genes associated with ARDs were con-
sidered. Figure 8 shows the number of genes per ARD class and
the number of genes shared with each one of the remaining
classes. The list of ARDs used in the present analysis is summa-
rized in Supplementary Material, Table S20. In total, 40 diseases
were part of ARD classes, of which 22 ARDs were analysed indi-
vidually. The list of all age-related diseases and their related
genes is available in the supplementary material
(Supplementary Dataset 5). Our full datasets are also available
on GitHub (https://github.com/maglab/genage-analysis).
Protein–protein interaction and gene co-expression data
Protein–protein interactions were obtained using the BioGRID
plug-in available in Cytoscape, on 16-04-2015, by downloading
the available node and edge tables. The two main types of inter-
actions (‘physical association’ and ‘direct interaction’) represent
124,238 of 140,891 interactions, involving 14,721 of 15,000 pro-
teins. As such, the interactome analysis was performed using
the full interactome. To obtain the first-order partners of aging-
related genes, a Python script was used to compile connections
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between all genes in the interactome and return the merged list
of seed genes and genes connected to them.
Co-expression data from RNA-Seq was obtained using
GeneFriends (22) on 03-06-2015. To obtain the co-expressed
genes, a significance threshold of 2.5E-06 was applied to the p-
value retrieved from GeneFriends. The threshold was defined by
correction of standard a (0.05) using a Bonferroni correction
where N represents the genome size (20183 genes).
Publication bias correction (PBC)
The number of publications was compiled from the Swiss-Prot
PubMed annotation list, downloaded on 23-04-2015. Only human
and reviewed genes were considered for this analysis. Although
PubMed publications annotated in Swiss-Prot are not the total
number of publications for each entry, they represent a curated
selection. Thus, Swiss-Prot was selected as the source for the
number of publications due to its curated nature, which makes it
a reliable source of annotated data for protein coding genes.
Gene features
The list of all human genes was collected from GenBank on 31-01-
2015. For this analysis, only human annotated and protein-coding
genes were considered, which represent a set of 20,183 genes.
Molecular evolutionary rate (dN/dS) was calculated from the
number of synonymous (dN) and non-synonymous (dS) substi-
tutions downloaded from Ensembl BioMart, selecting the
Ensembl Genes 80 database and Homo sapiens genes (GRCh38.p2)
dataset on 17-05-2015. Of all the model organisms considered in
the present work, only mouse orthologs present dN and dS val-
ues, due to the great evolutionary distance shown by the other
organisms. Thus, all dN/dS ratio comparisons consider the evo-
lution between mice and humans.
Feature selection method
We used a recently proposed feature selection method, from the
area of data mining (or machine learning) to select the relevant
Gene Ontology (GO) terms for predicting the pro-longevity or anti-
longevity effect of a gene on a model organism (8). In essence, we
addressed the classification task of data mining, where the goal is
to predict the class (pro- or anti-longevity effect) of an instance (a
gene) based on predictive features (GO terms) associated with that
gene. The used feature selection method differs from other feature
selection methods typically used in data mining in two important
ways, as follows. First, it selects a specific set of features relevant
for the classification of each instance, instead of selecting the
same set of features for all instances, as usual in data mining.
This increases the flexibility of the feature selection process, rec-
ognizing that the optimal set of GO terms for predicting the pro-
or anti-longevity effect of a gene varies across different genes.
Second, the used method performs ‘hierarchical’ feature selection,
in the sense that it takes into account the hierarchical structure of
the GO in order to improve the feature selection process; unlike
conventional (‘flat’) feature selection methods.
That feature selection method was applied to datasets with
data about aging-related genes from the four traditional model or-
ganisms, namely: mouse, fly, roundworm and yeast. The results
of the feature selection method were transformed into a rank
of GO terms as follows. For each dataset (model organism), for
each GO term, we counted the number of instances (genes) where
that GO term was one of the relevant features selected by the
feature selection method for predicting the pro- or anti-longevity
effect of the gene. Then, we ranked the GO terms in decreasing or-
der of this frequency of selection. We also used a statistical test of
significance based on the binomial distribution to detect which
GO terms were significantly associated with the class being pre-
dicted. A detailed description of the feature selection method and
how its results were used to rank the GO terms can be found in (8).
Overlap analysis
A significant overlap between aging-related genes and ARDs is
defined as: i) an observed number of CAD-genes above the num-
ber of CAD-genes expected by chance; and ii) a p-value below
0.05 (Fisher’s exact test). Genome and interactome analysis
used whole genome and interactome as background, respec-
tively. The background for the first order partners analysis was
the seed list plus the interactome and was adjusted for each ag-
ing gene set since the seed list varies between different aging
sets. In this analysis, the interactome was added to the back-
ground since the first order partners were selected from that
group.
Functional enrichment analysis
Functional enrichment analysis using the Database of
Annotation Visualization and Integrated Discovery (DAVID) (33)
was performed to identify overrepresented categories. The anal-
ysis was done by running the Functional Annotation Clustering
module under default parameters. Unless otherwise stated, the
whole genome was used as background. Enrichment scores (E.
Score) above 1.3 (which corresponds to P¼ 0.05) are widely ac-
cepted as relevant (33); however, in this analysis a threshold of
2.5 (corresponding to P¼ 0.003) was used for more significant re-
sults. A Benjamini correction was applied for correcting for mul-
tiple hypothesis testing.
Candidate drugs from GenAge targets
To identify candidate drugs with possible anti-aging properties,
the Drug Gene Interaction Database (DGIdb) version 2 (34) was
used. We classified all 44 types of drug-gene interactions in
DGIDB into either ‘Anti’ (decrease gene expression or activity) or
‘Pro’ (increase gene expression or activity) or ‘Neither’ (non-ap-
plicable or undefined effects), so that they can be matched with
GenAge genes to obtain a putative lifespan-extending effect
(Supplementary Material, Table S5). Drugs were obtained by
considering if they interact with GenAge genes in a way that
would be predicted to extend lifespan. That is, for an ‘Anti’
drug, only the interactions with anti-longevity genes are scored;
and vice-versa for ‘Pro’ drugs.
In total, 376 drugs were obtained which were ordered based
on ascending P-value obtained using a one-tailed hypergeomet-
ric test. After Bonferroni correction (a¼ 0.05), 20 statistically sig-
nificant drugs were obtained.
Supplementary Material
Supplementary Material is available at HMG online.
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